M&A Deal Summary

Piramal Enterprises Acquires Ash Stevens

On August 16, 2016, Piramal Enterprises acquired life science company Ash Stevens for 43M USD

Acquisition Highlights
  • This is Piramal Enterprises’ 5th transaction in the Life Science sector.
  • This is Piramal Enterprises’ 3rd largest (disclosed) transaction.
  • This is Piramal Enterprises’ 5th transaction in the United States.
  • This is Piramal Enterprises’ 1st transaction in Michigan.

M&A Deal Summary
Date 2016-08-16
Target Ash Stevens
Sector Life Science
Buyer(s) Piramal Enterprises
Deal Type Add-on Acquisition
Deal Value 43M USD
Advisor(s) Wells Fargo Securities (Financial)
Morrison & Foerster (Legal)

Target

Ash Stevens

Riverview, Michigan, United States
Ash Stevens, Inc. is a full-service pharmaceutical contract manufacturer and serves several biotech, mid-size pharma, and large pharmaceutical clients worldwide. Its develops drug substances and manufacturing active pharmaceutical ingredients (APIs).

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Piramal Enterprises

Mumbai, India
Category Company
Founded 1947
Sector Healthcare Services
Employees3,000
Revenue 81.1B INR (2024)
DESCRIPTION

Piramal Enterprises is a diversified Indian conglomerate. Piramal Group operates healthcare, drug discovery and research, glass, real estate and financial services. Piramal Enterprises was founded in 1947 and is based in Mumbai, India.

DEAL STATS #
Overall 10 of 12
Sector (Life Science) 5 of 6
Type (Add-on Acquisition) 5 of 6
State (Michigan) 1 of 1
Country (United States) 5 of 5
Year (2016) 1 of 1
Size (of disclosed) 3 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-04-01 Piramal Clinical Research

India

Piramal Clinical Research specializes in conducting bioequivalence and bioanalytical studies for generic products.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-01-30 Mallinckrodt - Intrathecal Therapy Business

Dublin, Ireland

Mallinckrodt plc - Intrathecal Therapy Business includes Gablofen® (baclofen), a severe spasticity management product, which is currently marketed in the United States, and two pain management products, which are currently under development.

Buy $171M
Mergr

Product

Company

Legal